Skip to main content

Animations

MJFF Publications

3861 - 3870 of 6422 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2023
  • 2023
  • 2022
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29202
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.1061096
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Neuropathologic validation of the Alzheimer’s Questionnaire
    Journal Name: Aging Clinical and Experimental Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s40520-022-02222-9
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awac294
    Citation Count: 22
  • Summary Details
    OPEN
    Title: The image and data archive at the laboratory of neuro imaging
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2023.1173623
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
    Journal Name: Journal of Patient-Reported Outcomes
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s41687-023-00577-9
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The genetic regulation of protein expression in cerebrospinal fluid
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202216359
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-022-00290-0
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Golgi-IP, a tool for multimodal analysis of Golgi molecular content
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2219953120
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model ofGBA1-associated Parkinson’s disease
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddad025
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.